These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2981368)

  • 1. HTLV-III testing of donor blood imminent; complex issues remain.
    Goldsmith MF
    JAMA; 1985 Jan; 253(2):173-5, 179-81. PubMed ID: 2981368
    [No Abstract]   [Full Text] [Related]  

  • 2. Status report on the acquired immunodeficiency syndrome. Human T-cell lymphotropic virus type III testing. Council on Scientific Affairs.
    JAMA; 1985 Sep; 254(10):1342-5. PubMed ID: 2991616
    [No Abstract]   [Full Text] [Related]  

  • 3. How should we handle the ethical questions regarding information to donors and patients and the practical implications regarding deferral of donors and handling of donated blood in the event of introducing a screening test for HTLV-III as in order to prevent transmission of AIDS by blood transfusion?
    Bove JR; Dodd RY; Miller WV; Sandler SG
    Vox Sang; 1985; 49(3):234-9. PubMed ID: 2996229
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?
    Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF
    N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood banks give HTLV-III test positive appraisal at five months.
    Marwick C
    JAMA; 1985 Oct; 254(13):1681-3. PubMed ID: 2993686
    [No Abstract]   [Full Text] [Related]  

  • 7. Infectious complications of blood transfusions.
    Berkman SA
    Semin Oncol; 1984 Mar; 11(1):68-76. PubMed ID: 6326332
    [No Abstract]   [Full Text] [Related]  

  • 8. Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity.
    Petricciani JC
    Ann Intern Med; 1985 Nov; 103(5):726-9. PubMed ID: 2996408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [LAV/HTLV-III antibodies in blood and blood products].
    Gürtler L; Eberle J; Deinhardt F
    Dtsch Med Wochenschr; 1985 Oct; 110(43):1639-40. PubMed ID: 2994977
    [No Abstract]   [Full Text] [Related]  

  • 10. HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins.
    Lange JM; van den Berg H; Dooren LJ; Vossen JM; Kuis W; Goudsmit J
    J Infect Dis; 1986 Jul; 154(1):171-4. PubMed ID: 3011923
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for HTLV-III antibodies--a government blunder?
    Bryan CS
    J S C Med Assoc; 1985 Apr; 81(4):242-4. PubMed ID: 2985870
    [No Abstract]   [Full Text] [Related]  

  • 13. Consensus conference. The impact of routine HTLV-III antibody testing of blood and plasma donors on public health.
    JAMA; 1986 Oct; 256(13):1778-83. PubMed ID: 3018308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-III and blood donors.
    Lancet; 1985 Apr; 1(8433):856. PubMed ID: 2858715
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress on AIDS.
    FDA Drug Bull; 1985 Oct; 15(3):27-32. PubMed ID: 2996963
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for HTLV-III antibodies: the relation between prevalence and positive predictive value and its social consequences.
    JAMA; 1985 Jun; 253(23):3395-8. PubMed ID: 2987557
    [No Abstract]   [Full Text] [Related]  

  • 18. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to HTLV-III in blood donors in central Africa.
    Van de Perre P; Munyambuga D; Zissis G; Butlzer JP; Nzaramba D; Clumeck N
    Lancet; 1985 Feb; 1(8424):336-7. PubMed ID: 2857383
    [No Abstract]   [Full Text] [Related]  

  • 20. HTLV-III antibody testing in three Danish blood banks.
    Orskov Lindhardt B; Ulrich K; Ryder L; Dickmeiss E; Sørensen H; Jørgensen J; Jersild C; Grunnet N
    Vox Sang; 1986; 51 Suppl 1():9-14. PubMed ID: 3017006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.